Tag: Generics

Astellas and FibroGen’s Evrenzo® Approved in Japan

astellas
Astellas Pharma Inc. and FibroGen, Inc. announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved Evrenzo® (generic name: roxadustat) for the treatment of anemia associated with ch...

Mylan Announced U.S. Launch of Generic Fulvestrant Injection

mylan
Mylan N.V. announced the U.S. launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per single-dose prefilled syringe, a generic version of AstraZeneca's Faslodex® Injection. Mylan received final...

Daiichi Sankyo Launched Oxycodone Extended Release Tablets NX “Daiichi Sankyo” in Japan

Daiichi Sankyo Company Limited announced it has launched a new generic formulation of oxycodone hydrochloride hydrate extended release tablets for sustained cancer pain treatment in Japan: Oxycodone E...

Biocon Signed Agreement with Subsidiary of CMS for Three Generic Formulation Products

biocon
Biocon Ltd, Asia’s premier biopharmaceuticals company, announced that it has signed a License and Supply Agreement with a subsidiary of China Medical System Holdings Ltd. (CMS) for three Generic Formu...

Strides to Acquire Majority Stake in Fairmed

Strides Pharma Science Limited has announced its acquisition of majority stake in Fairmed Healthcare AG. Strides Pharma Global Pvt Ltd (SPG) is a step down subsidiary of Strides Pharma Science Limi...

Dr Reddy’s to Launch Fosaprepitant for Injection in US

Dr Reddy's Laboratories Ltd announced launch of Fosaprepitant for Injection the therapeutic generic equivalent of USFDA approved EMEND (fosaprepitant) for injection in the US market. We are pleased t...

NHS Plan to Use More Generics Could Save Up to £700m

An NHS-wide plan to use more generic and biologic products has reportedly saved the healthcare provider £700 million since 2016. The National Health Service (NHS), UK, has announced that its initiati...

FDA Granted Final Approval for Pimecrolimus Cream

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Pimecrolimus Cream, 1%, a generic version of Elidel® Cr...

FDA Approved Glenmark’s Fulvestrant Injection

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Fulvestrant Injection, 250 mg/5 mL (50 mg/mL), a generic version o...

Teva Launches Generic of Mylan’s EpiPen for Young Children

Teva Pharmaceutical Industries Ltd said on Tuesday its generic version of Mylan’s EpiPen for young children will be available in most retail pharmacies at a price of $300 for a 2-pack. Israel-based...

FDA Approved Generic Version of Hygroton Tablets

Drug firm Unichem Laboratories has received approval from the US health regulator to market Chlorthalidone tablets, used to treat high blood pressure.  The company has received abbreviated new drug...

Korea Becomes Increasingly Attractive to International Pharma Due to Generics Drive

korea
A surge of international partnerships and biosimilars is helping drive Korea’s pharmaceutical market, new findings show. Provisional data from the CPhI Annual Report 2019 shows that areas...

FDA Approved Multiple Applications for First Generics of Lyrica

On July 19, the U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associated with diabetic peripheral ne...

Vision of Russia’s Generic Market Development

The human body is subject to many diseases, so without drugs it simply can not cope. The health of people, the improvement of the quality of life and its duration are the main goals of pharmaceutical ...

Astellas Pharma Announced the Launch of the Smyraf® Tablets

astellas
Astellas Pharma Inc. announced the launch of the Smyraf® 50 mg and 100 mg Tablets (generic name: peficitinib hydrobromide), an oral Janus kinase (JAK) inhibitor, in Japan for the treatment of rheumato...

Lupin Launches Generic of Novartis’ Gleevec®

Lupin Limited (Lupin) announced the launch of Imatinib Mesylate Tablets, 100 mg (base) and 400mg (base). Lupin's alliance partner Natco had received an approval from the United States Food and Drug Ad...